Bioprosthetic valve fracture to facilitate valve-in-valve transcatheter aortic valve repair
- PMID: 33312917
- PMCID: PMC7724067
- DOI: 10.21037/acs-2020-av-20
Bioprosthetic valve fracture to facilitate valve-in-valve transcatheter aortic valve repair
Conflict of interest statement
Conflicts of Interest: KBA—Edwards Lifesciences: Research Support, Proctor, Speakers Bureau; Medtronic: Research Support, Speakers Bureau; Abbott: Research Support, Consulting; Boston Scientific: Consulting. AKC—Abbott Vascular: Speakers Bureau; Boston Scientific: Research support, consulting; Edwards Lifesciences: Proctor, Speakers Bureau; Medtronic Inc: Proctor, Speakers Bureau. JS—Edwards Lifesciences and Medtronic: Consulting. DD—Consulting for Edwards Lifesciences, Medtronic, Abbott. JGW—Consulting for Edwards Lifesciences, Abbott, Boston Scientific. JTS has no conflicts of interest to declare.
Figures
References
-
- Chhatriwalla A, Allen KB, Saxon J, et al. One year outcomes following bioprosthetic valve fracture to facilitate valve-in-valve transcatheter aortic valve replacement. J Am Coll Cardiol 2020;75:1106 10.1016/S0735-1097(20)31733-2 - DOI
Publication types
LinkOut - more resources
Full Text Sources